Form 4: Fulgent Genetics CEO Ming Hsieh Reports Stock Transaction
SEC Form 4 Filing
CEO Ming Hsieh reports disposition of Fulgent Genetics shares to cover tax obligations from vesting restricted stock units.
Summary
- On February 23, 2024, Ming Hsieh, CEO of Fulgent Genetics, disposed of 8,667 shares of common stock at a price of $24.06 per share to cover tax obligations.
- Following the transaction, Hsieh directly owns 632,702 shares.
- Hsieh also indirectly owns 220,816 shares through the Dynasty Trust, 7,895,115 shares through The Ming Hsieh Trust, and 2,000 shares through Uniform Transfers to Minor Act accounts.
- The Dynasty Trust's investment committee includes Mr. Hsieh, his spouse Eva Hsieh, and Jian Xie.
- Mr. Hsieh is the trustee of The Ming Hsieh Trust and acts as custodian for the Uniform Transfers to Minor Act accounts.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a routine stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 02/23/2023 | Date of restricted stock units grant to the reporting person. |
| 02/27/2023 | Date of original Form 4 filing reporting the restricted stock units grant. |
| 02/23/2024 | Date of the stock transaction (disposal of shares). |
| 02/27/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.